Source-Specific PM 2.5 and Atherosclerotic Cardiovascular Disease Mortality
NEJM Evidence · 2024
DOI: 10.1056/evidoa2400182 ↗Kurz gefasst
Fachartikel in der Zeitschrift NEJM Evidence, 2024. Verfasst von Tszshan Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta. Hauptthemen laut MEDLINE: Particulate Matter, Atherosclerosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NCATS NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta.
- Department of Environmental Medicine and Climate Science, Icahn School of Medicine at Mount Sinai, New York.
- Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York.
- Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston.
Förderung
- NIEHS NIH HHS
- NCATS NIH HHS
- NIA NIH HHS
Zitieren
APA
Ma, T., Knobel, P., Hadley, M., Colicino, E., Amini, H., Federman, A., Schwartz, J., Steenland, K., & Sade, M. Y. (2024). Source-Specific PM 2.5 and Atherosclerotic Cardiovascular Disease Mortality. NEJM Evidence. https://doi.org/10.1056/evidoa2400182
Vancouver
Ma T, Knobel P, Hadley M, Colicino E, Amini H, Federman A, et al. Source-Specific PM 2.5 and Atherosclerotic Cardiovascular Disease Mortality. NEJM Evidence. 2024. doi:10.1056/evidoa2400182
BibTeX
@article{Ma2024,
author = {Ma, Tszshan and Knobel, Pablo and Hadley, Michael and Colicino, Elena and Amini, Heresh and Federman, Alex and Schwartz, Joel and Steenland, Kyle and Sade, Maayan Yitshak},
title = {Source-Specific PM 2.5 and Atherosclerotic Cardiovascular Disease Mortality},
journal = {NEJM Evidence},
year = {2024},
doi = {10.1056/evidoa2400182}
}
EUVIMED